Lacktman Quoted on New Telemedicine Laws in Oklahoma, Texas
August 2, 2017
Bloomberg BNA
Partner Nate Lacktman was quoted in a Bloomberg BNA article, “New State Telemedicine Laws Show Provider Hurdles Remain,” covering the pros and cons of the new telemedicine laws in Oklahoma and Texas, and the evolution of telemedicine as a whole.
Lacktman said, “Although there is relative consistency and homogeneity in how state laws define the ‘practice of medicine,’ state law definitions of telemedicine are varied, as are state telemedicine practice standards. Telemedicine providers would benefit if state legislatures and medical boards used consistent definitions, such as the model language contained in the Federation of State Medical Boards’ [Model Policy for the Appropriate Use of Telemedicine Technologies].”
“There is an evolution at play for telemedicine regulation,” he continued later. “When we started, most states had no telemedicine rules, and providers asked for laws that affirmatively stated ‘yes, you may use telemedicine.’ A decade later, providers are asking to make those same rules less onerous and more flexible.”
Lacktman said, “Although there is relative consistency and homogeneity in how state laws define the ‘practice of medicine,’ state law definitions of telemedicine are varied, as are state telemedicine practice standards. Telemedicine providers would benefit if state legislatures and medical boards used consistent definitions, such as the model language contained in the Federation of State Medical Boards’ [Model Policy for the Appropriate Use of Telemedicine Technologies].”
“There is an evolution at play for telemedicine regulation,” he continued later. “When we started, most states had no telemedicine rules, and providers asked for laws that affirmatively stated ‘yes, you may use telemedicine.’ A decade later, providers are asking to make those same rules less onerous and more flexible.”
People
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.